Skip to main content
. 2020 Aug 25;12(9):2406. doi: 10.3390/cancers12092406

Table 2.

List of lncRNAs associated with taxane resistance.

Name of lncRNA Classification Type of Cancer Role in Drug Resistance Mechanism Reference
UCA1 (urothelial carcinoma associated 1) Intergenic Ovarian cancer ↑ PTX resistance Sponging miR-129 → ↑ ABCB1-induced drug efflux
Regulating miR-654-5p/SIK2 axis
[131]
[132]
LINC01118 Intergenic Ovarian cancer ↑ PTX resistance Regulating miR-134/ABCC1 axis [133]
NEAT1 (nuclear paraspeckle assembly transcript 1) Intergenic Ovarian cancer ↑ PTX resistance Sponging miR-194 → ↑ ZEB1 expression → ↑ EMT [134]
NEAT1 (nuclear paraspeckle assembly transcript 1) Intergenic Endometrial cancer ↑ PTX resistance Sponging miR-194 → ↑ STAT3 expression [135]
SNHG5 (small nucleolar RNA host gene 5) Intergenic Ovarian cancer ↓ PTX resistance Sponging oncogenic miR-23a [136]
SDHAP1 (succinate dehydrogenase complex, subunit A, flavoprotein pseudogene 1) Pseudogene Ovarian cancer ↑ PTX resistance Regulating miR-4465/EIF4G2 axis [137]
HEIH (highly expressed in hepatocellular carcinoma) Intergenic Endometrial cancer ↑ PTX resistance Activating MAPK pathway [138]
FER1L4 (fer-1 like family member 4) Pseudogene Ovarian cancer ↓ PTX resistance ↓ Phosphorylation of MAPK [139]
LINC00312 (long intergenic non-protein coding RNA 312) Intergenic Ovarian cancer ↓ PTX resistance Blocking BCL-2 expression and activating Bax/Caspas3 apoptotic pathways [140].
ANRIL (antisense non-coding RNA in the INK4 locus) Antisense Endometrial cancer ↑ PTX resistance Regulating both miR-125a-5p/Bcl2 and miR-125a-5p/MRP4 axes [141]
KB-1471A8.2 Antisense Ovarian cancer ↓ PTX resistance Blocking S-phase entry and CDK4 [142]
CTD-2589M5.4 Intergenic Ovarian cancer Associated with multidrug resistance Unknown but may be related to ABCB1, ABCB4, ABCC3, and ABCG2 [143]

The arrows in this table refer to: ↑ (increase); ↓ (decrease); → (leading to).